Literature DB >> 30606634

In Vivo Characterization of Corneal Changes in a Type 1 Diabetic Animal Model.

Miguel Caixinha1, Pedro Oliveira2, Inês D Aires3, António Francisco Ambrósio3, Ana Raquel Santiago3, Mário Santos4, Jaime Santos4.   

Abstract

Diabetes mellitus (DM) is a metabolic disease that affects 9% of the adult population, promoting an increase in glucose concentration that affects the corneal structure, namely, its thickness, as well as the constituents and flow of the aqueous humor. In this study, high-frequency transducers (20-MHz and 50-MHz) were used to measure and characterize changes in the corneal and aqueous humor in streptozotocin-induced type 1 diabetic rats followed over 8 weeks. Increases of 24.6 and 15.4 μm in central corneal thickness were measured with the 20-MHz and 50-MHz probes, respectively, in DM rats (p < 0.001). The increases in thickness of the different corneal layers ranged from 7% to 17%. Structural alterations of the aqueous humor were also studied by relating the amplitudes of the anterior lens and posterior cornea boundary signals, the result of which was denominated by pseudo-attenuation. The results revealed an increase of 49% at week 8 compared with the baseline values (p < 0.020, with the 50-MHz probe). This study illustrated that high-frequency ultrasound can be used to measure corneal layer thickness and study the alterations promoted by diabetes in the eye's anterior segment. Those assessments may allow early detection of DM, improving the monitoring of diabetic patients.
Copyright © 2018 World Federation for Ultrasound in Medicine & Biology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cornea; Diabetes mellitus; Ultrasound

Year:  2018        PMID: 30606634     DOI: 10.1016/j.ultrasmedbio.2018.11.002

Source DB:  PubMed          Journal:  Ultrasound Med Biol        ISSN: 0301-5629            Impact factor:   2.998


  1 in total

Review 1.  Corneal alteration and pathogenesis in diabetes mellitus.

Authors:  Han Zhao; Yan He; Yue-Rong Ren; Bai-Hua Chen
Journal:  Int J Ophthalmol       Date:  2019-12-18       Impact factor: 1.779

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.